Varex to Highlight Advanced Imaging Components at Medica in Dusseldorf
Varex Imaging Corporation (Nasdaq: VREX) today announced it will showcase its digital detectors, X-ray imaging tubes, connect and control devices and software solutions at Medica 2019. Medica is attended by leaders in the fields of business and research, and international experts and decision-makers from the medical sector covering the entire spectrum of innovations for outpatient and clinical care.
Varex will also promote its ‘Local for Local’ campaign at Medica 2019 and introduce the company’s Service Solutions Group, which has been developed to provide local service to our customers with increased local X-ray tube and digital detector manufacturing and the aim of being global partners for local business.
“Our aim is to bring innovative X-ray imaging components to imaging systems manufacturers and we want to make that as easy as possible for our customers. By establishing local commercial relationships, delivering local service and support, and sourcing from local suppliers, we can be a global company and offer enhanced service capability that is local, hands-on, responsive, and easy to reach,” said Sunny Sanyal, Chief Executive Officer of Varex Imaging Corporation.
At Medica 2019, Varex will be highlighting its service and support and European customer experience by:
- enabling on-time delivery for common X-ray tube types in the radiological range of key brands
- providing technical support, evaluations and repairs of Varex digital detector flat panels/X-ray tubes at the company’s service centre in Willich, Germany
- giving access to local expert technical support for CT software, Nexus trainings and inquiries about X-ray detectors and tubes
Varex will be displaying a selection of their extensive portfolio of real-time digital X-ray imaging flat panel detectors (FPDs) at Medica 2019. Varex FPDs are developed using a variety of imaging technologies – amorphous silicon, CMOS and IGZO, which provide different benefits ideally suited to specific medical applications. For Surgery, Varex is showcasing 2020DXV/2121DXV and 3030DXV which are cost-efficient, high performance panels for Image Intensifier replacement. The company is also introducing the Varex Z platform which offers a new performance level with higher resolution and improved low dose performance over Amorphous Silicon, but without the cost burden of CMOS. Varex Z platform is based on IGZO technology and is very suitable for fluoroscopy applications with their bright scintillators, new electronics and fast interfaces. For Radiography, Varex will be showcasing its complete range of high value (2530W, 4336Wv4, 4343W) and high definition (XRpad2 3025, XRpad2 4336, XRpad2 4343) wireless panels. The Varex team of imaging experts will be on hand at Medica 2019 to advise customers on technology and packaged component solutions that are most suitable for their application; be it Radiography, Mammography, Fluoroscopy or Computed Tomography (CT). Varex Imaging will be providing Solutions in Sight™ at Medica 2019.
At Varex, we aren’t just a supplier to our customers. We aim to be an extension of their teams; a partner in their success; a solution to their problem. Our goal is to enable our customers to become world-class system suppliers by strengthening their competitiveness and enabling them to bring products to market faster. Our rich history spans 65+ years of dedication to the imaging industry. Our knowledge, our people, and our innovation make us who we are. At Varex, we are Solutions in Sight™.
For more information about Varex visit: www.vareximaging.com.
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Sabio Group Acquires Coverage Group in France6.7.2020 11:00:00 EEST | Press release
Sabio Group has announced the acquisition of Coverage Group, one of France’s leading independent providers of customer experience and communications technology solutions. The acquisition supports Sabio’s goal of becoming the leading player across the European CX market and will add significant scale to the company’s French operations. Formed in 2007, Paris-based Coverage Group is an established Genesys Gold, Avaya Edge, Oracle Gold and Broadsoft technology partner. The company has a proven track record in helping organisations across France to place cloud-based customer experience solutions at the heart of their digital strategy, with customers including ENGIE, BEA, EBP, Emil Frey, Homeserve, NutriXo, Optimind, Pierre Fabre, Pierre & Vacances, Sitel and Teleperformance. “The acquisition is a massively important strategic addition for Sabio Group and our customers in a number of ways – it means we have now built a substantial presence and customer base in France, it further strengthens
BearingPoint helps government and public sector organizations deliver critical health and public services during the Covid-19 pandemic6.7.2020 10:00:00 EEST | Press release
Management and technology consultancy BearingPoint announced today that it is helping its government and public sector clients across Europe to deliver critical health and public services during the Covid-19 pandemic through new delivery models, new ways of working, digitalization, and automation. “BearingPoint’s organization as a single, European-based business has meant we have been able to draw on capabilities, leading practices and learnings from across our government and public sector clients and teams in many different countries. Working remotely and in partnership with our clients, we have quickly mobilized resources to design and deliver solutions to support both the public services needed during Covid-19 and the new ways of working for public servants,” said Andrew Montgomery, Partner and Global Leader Government and Public Sector at BearingPoint. New delivery models and services People’s health and well-being during the Covid-19 crisis have required public services to rapidly
DNA Selects VisualOn’s OnStream® Android TV to Deliver the Highest Quality of Service for Their Over the Top (OTT) Deployment on the Android TV Platform6.7.2020 09:00:00 EEST | Press release
VisualOn, Inc., a streaming software provider that enables scalable, cross-platform media playback for leading video services, today announced that the company is now providing DNA's end users the ability to stream the highest quality video using the Android TV. DNA is Finland's largest cable operator. Launched in February this year, the new DNA TV has revamped DNA’s TV offering for IP-based delivery, introducing multiple features including unlimited NPVR recordings, a new user interface and improved video stream quality. Through its innovative program-centric approach, subscribers can view and record unlimited TV programs with unprecedented ease of use and watch live and VOD content whenever they want, anywhere in the EU via the DNA TV app. Furthermore, the service delivers compelling content recommendations based on users’ individual viewing preferences. VisualOn, powered by AWS, has closely supported DNA to build and deploy this platform. “Service reliability and a seamless user exp
Excelya Welcomes Three European Contract Research Organizations to Become One Stop Provider Throughout Europe6.7.2020 09:00:00 EEST | Press release
Today, Excelya, a leading contract research organization (CRO) specializing in clinical research, announced that three European CROs joined Excelya Group: Zeincro based in Central-Eastern & Southern Europe, The Clinical Company based in the Netherlands and Belgium and Koehler eClinical based in Germany. Together, they will be known as Excelya Group. This alliance will allow Excelya to offer a one stop provider service model throughout Europe for its clients, whether they need full service, functional service providing or consulting services. Zeincro is a leading contract research organization primarily operating in Central-Eastern & Southern Europe with particular expertise in clinical operations, safety and medical affairs. The Clinical Company is present in the Belgian and Dutch markets specializing in clinical operations. Koehler eClinical is a German specialty CRO with a focus on biostatistics and data solutions. Thanks to the unification with these three companies, Excelya Group i
EMA Validates and Grants Accelerated Assessment for Trastuzumab Deruxtecan for the Treatment of HER2 Positive Metastatic Breast Cancer6.7.2020 09:00:00 EEST | Press release
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) for trastuzumab deruxtecan, a HER2 directed antibody drug conjugate (ADC), for the treatment of adults with unresectable or metastatic HER2 positive breast cancer who have received two or more prior anti-HER2 based regimens. Trastuzumab deruxtecan was granted accelerated assessment by the EMA’s Committee for Medicinal Products for Human Use (CHMP). Validation confirms that the application is complete and commences the scientific review process by the EMA’s CHMP. Accelerated assessment is granted by the CHMP to products expected to be of major interest for public health and therapeutic innovation and can significantly reduce the review timelines. “The accelerated assessment highlights the significant unmet need for patients with HER2 positive metastatic breast cancer that trastuzumab deruxtecan aims at addressing
Study Investigates Accuracy of Respiration Rate Obtained From Pulse Oximetry on Pediatric Patients Using Masimo RRp®6.7.2020 09:00:00 EEST | Press release
Masimo (NASDAQ: MASI) today announced the results of a study published in Pneumonia in which independent researchers in New Delhi, India, investigated the accuracy of Masimo RRp® on pediatric patients with the Rad-G™ Pulse Oximeter by comparing it to clinician-determined values while performing routine assessment of children admitted to outpatient and emergency departments.1 RRp provides respiration rate determined from the photoplethysmograph used in pulse oximetry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200705005031/en/ Masimo Rad-G™ with RRp® (Photo: Business Wire) Noting the high incidence of childhood pneumonia in many parts of the world, the inclusion of oxygen saturation (SpO2) and respiratory rate measurement in pneumonia screening guidelines, and the scarcity of medical equipment and variability in medical training in many low-resource settings, Dr. Alwadhi and colleagues sought to determine whether a “multi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom